Several key markers define E-cadherin is often downregulated in aggressive CRC, whereas mesenchymal markers such as N-cadherin, vimentin, and matrix metalloproteinases are upregulated, facilitating tumor invasion and metastasis (26). Here, CDH2 is linked to neoplasm.